{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:16:28Z","timestamp":1789661788974,"version":"4.0.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Sepsis trials likely include patients who vary in response to therapeutic interventions. The optimal approach to identify such differences in treatment response remains unclear. Estimating individualized absolute risk differences (iARDs) to model treatment response at an individual patient level using supervised effect models applied to randomized trial data may be informative. We explored the relationship between two subgrouping approaches and a recently published iARD model for the effect of early goal-directed therapy (EGDT) resuscitation in sepsis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Secondary analysis of the Protocolized Care for Early Septic Shock (ProCESS) and Australasian Resuscitation in Sepsis Evaluation (ARISE) trials. We applied clinical subtypes (\u03b1, \u03b2, \u03b3, \u03b4) to 829 ProCESS and 1588 ARISE patients and biologic \u201chyperinflammatory\u201d and \u201cnonhyperinflammatory\u201d subphenotypes to 363 ProCESS patients with biomarker data using established methods. We predicted iARDs with supervised learning using clinical variables as predictors and 90-day mortality as the primary outcome. We evaluated iARD variability within subgroups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Eighty-one sites worldwide.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS\/SUBJECTS:<\/jats:title>\n            <jats:p>Adults with septic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>EGDT or usual care.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>The average treatment effect of EGDT appeared to vary within both clinical and biologic subphenotypes. EGDT appeared potentially beneficial in the \u03b2 and nonhyperinflammatory subphenotypes but harmful in the \u03b3 and hyperinflammatory subphenotypes. However, the predicted iARDs within each subgroup ranged from considerable harm to considerable benefit. For example, for the \u03b2-subtype, the average mortality reduction from EGDT was 8.5% (95% CI, \u20130.4 to 17.5), but the iARDs ranged from a 29% increase to a 16% reduction in mortality, with 39% of patients predicted to be harmed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Although both clinical and biologic phenotyping may identify subgroups whose average treatment effect is beneficial or harmful, individual risks and benefits within subgroups still vary dramatically, raising concern that phenotyping may not reliably or safely personalize sepsis care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001332","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:07:43Z","timestamp":1760702863000},"page":"e1332","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Relationship Between Phenotyping and Individualized Absolute Risk Differences in Sepsis: A Secondary Analysis of Two Approaches in Two Multicenter Trials"],"prefix":"10.1097","volume":"7","author":[{"given":"Victor B.","family":"Talisa","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Center for Research, Investigation, and Systems Modeling of Acute Illness, School of Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin P.","family":"Yende","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Center for Research, Investigation, and Systems Modeling of Acute Illness, School of Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Integrated Veteran Care, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek C.","family":"Angus","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Center for Research, Investigation, and Systems Modeling of Acute Illness, School of Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[{"name":"Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia."},{"name":"Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia."},{"name":"Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia."},{"name":"Data Analytics Research and Evaluation, Austin Hospital, Melbourne, VIC, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Chou H.","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory F.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Intensive Care National Audit & Research Centre, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Higgins","sequence":"additional","affiliation":[{"name":"Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason N.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Center for Research, Investigation, and Systems Modeling of Acute Illness, School of Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian B.","family":"Mayr","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Center for Research, Investigation, and Systems Modeling of Acute Illness, School of Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mouncey","sequence":"additional","affiliation":[{"name":"Intensive Care National Audit & Research Centre, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Peake","sequence":"additional","affiliation":[{"name":"Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Rowan","sequence":"additional","affiliation":[{"name":"Intensive Care National Audit & Research Centre, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Triantafyllou","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Applied Mathematics, University of Crete, Crete, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Yealy","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Seymour","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Center for Research, Investigation, and Systems Modeling of Acute Illness, School of Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraaz Ali","family":"Shah","sequence":"additional","affiliation":[{"name":"Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA."},{"name":"Division of Pulmonary, Allergy, Sleep, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"R1-20251017","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/rccm.202108-1908ST","article-title":"A research agenda for precision medicine in sepsis and acute respiratory distress syndrome: An official American Thoracic Society research statement.","volume":"204","author":"Shah","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-20251017","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.3389\/fimmu.2018.01502","article-title":"Arguing for adaptive clinical trials in sepsis.","volume":"9","author":"Talisa","year":"2018","journal-title":"Front Immunol"},{"key":"R3-20251017","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-med-043021-014005","article-title":"Biological phenotyping in sepsis and acute respiratory distress syndrome.","volume":"74","author":"Sinha","year":"2023","journal-title":"Annu Rev Med"},{"key":"R4-20251017","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41581-019-0199-3","article-title":"Prognostic and predictive enrichment in sepsis.","volume":"16","author":"Stanski","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"R5-20251017","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis.","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"R6-20251017","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: Secondary analysis of a randomised controlled trial.","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R7-20251017","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1097\/CCM.0000000000002932","article-title":"Endotype transitions during the acute phase of pediatric septic shock reflect changing risk and treatment response.","volume":"46","author":"Wong","year":"2018","journal-title":"Crit Care Med"},{"key":"R8-20251017","doi-asserted-by":"crossref","first-page":"287ra271","DOI":"10.1126\/scitranslmed.aaa5993","article-title":"A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set.","volume":"7","author":"Sweeney","year":"2015","journal-title":"Sci Transl Med"},{"key":"R9-20251017","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00134-023-07239-w","article-title":"Uncovering heterogeneity in sepsis: A comparative analysis of subphenotypes.","volume":"49","author":"van Amstel","year":"2023","journal-title":"Intensive Care Med"},{"key":"R10-20251017","doi-asserted-by":"crossref","first-page":"103697","DOI":"10.1016\/j.ebiom.2021.103697","article-title":"Comparison of machine learning clustering algorithms for detecting heterogeneity of treatment effect in acute respiratory distress syndrome: A secondary analysis of three randomised controlled trials.","volume":"74","author":"Sinha","year":"2021","journal-title":"EBioMedicine"},{"key":"R11-20251017","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(97)09292-1","article-title":"Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST).","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"R12-20251017","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(98)11415-0","article-title":"Prediction of benefit from carotid endarterectomy in individual patients: A risk-modelling study. European Carotid Surgery Trialists\u2019 Collaborative Group.","volume":"353","author":"Rothwell","year":"1999","journal-title":"Lancet"},{"key":"R13-20251017","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/CCM.0000000000006371","article-title":"Toward precision in critical care research: Methods for observational and interventional studies.","volume":"52","author":"Graham Linck","year":"2024","journal-title":"Crit Care Med"},{"key":"R14-20251017","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","article-title":"A randomized trial of protocol-based care for early septic shock.","volume":"370","author":"Pro","year":"2014","journal-title":"N Engl J Med"},{"key":"R15-20251017","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMoa1404380","article-title":"Goal-directed resuscitation for patients with early septic shock.","volume":"371","author":"Peake","year":"2014","journal-title":"N Engl J Med"},{"key":"R16-20251017","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1038\/s41598-024-55667-5","article-title":"Identification of a hyperinflammatory sepsis phenotype using protein biomarker and clinical data in the ProCESS randomized trial.","volume":"14","author":"DeMerle","year":"2024","journal-title":"Sci Rep"},{"key":"R17-20251017","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1097\/CCM.0000000000006463","article-title":"Heterogeneity in the effect of early goal-directed therapy for septic shock: A secondary analysis of two multicenter international trials.","volume":"53","author":"Shah","year":"2024","journal-title":"Crit Care Med"},{"key":"R18-20251017","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1056\/NEJMoa1701380","article-title":"Early, goal-directed therapy for septic shock\u2014a patient-level meta-analysis.","volume":"376","author":"Rowan","year":"2017","journal-title":"N Engl J Med"},{"key":"R19-20251017","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","article-title":"From local explanations to global understanding with explainable AI for trees.","volume":"2","author":"Lundberg","year":"2020","journal-title":"Nat Mach Intell"},{"key":"R20-20251017","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","article-title":"Trial of early, goal-directed resuscitation for septic shock.","volume":"372","author":"Mouncey","year":"2015","journal-title":"N Engl J Med"},{"key":"R21-20251017","first-page":"2184","article-title":"Using group data to treat individuals: Understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence.","volume":"45","author":"Dahabreh","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R22-20251017","doi-asserted-by":"crossref","first-page":"d5888","DOI":"10.1136\/bmj.d5888","article-title":"Estimating treatment effects for individual patients based on the results of randomised clinical trials.","volume":"343","author":"Dorresteijn","year":"2011","journal-title":"BMJ"},{"key":"R23-20251017","doi-asserted-by":"crossref","first-page":"EVIDoa2300041","DOI":"10.1056\/EVIDoa2300041","article-title":"Individualized treatment effect prediction with machine learning\u2014salient considerations.","volume":"3","author":"Desai","year":"2024","journal-title":"NEJM Evid"},{"key":"R24-20251017","doi-asserted-by":"crossref","first-page":"agae049","DOI":"10.1093\/alcalc\/agae049","article-title":"Individualized treatment effects of a digital alcohol intervention and their associations with participant characteristics and engagement.","volume":"59","author":"Crawford","year":"2024","journal-title":"Alcohol Alcohol"},{"key":"R25-20251017","doi-asserted-by":"crossref","first-page":"e005010","DOI":"10.1161\/CIRCOUTCOMES.118.005010","article-title":"Clinical value of predicting individual treatment effects for intensive blood pressure therapy.","volume":"12","author":"Duan","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R26-20251017","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1038\/s41598-022-09775-9","article-title":"Individual treatment effect estimation in the presence of unobserved confounding using proxies: A cohort study in stage III non-small cell lung cancer.","volume":"12","author":"van Amsterdam","year":"2022","journal-title":"Sci Rep"},{"key":"R27-20251017","doi-asserted-by":"crossref","first-page":"e2029050","DOI":"10.1001\/jamanetworkopen.2020.29050","article-title":"Assessment of machine learning to estimate the individual treatment effect of corticosteroids in septic shock.","volume":"3","author":"Pirracchio","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R28-20251017","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jama.2023.3651","article-title":"Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19.","volume":"329","author":"Goligher","year":"2023","journal-title":"JAMA"},{"key":"R29-20251017","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1513\/AnnalsATS.202211-946OC","article-title":"Conditional treatment effect analysis of two infusion rates for fluid challenges in critically ill patients: A secondary analysis of balanced solution versus saline in intensive care study (BaSICS) trial.","volume":"20","author":"Zampieri","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"R30-20251017","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1164\/rccm.202209-1799OC","article-title":"Individualized treatment effects of Bougie versus stylet for tracheal intubation in critical illness.","volume":"207","author":"Seitz","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"R31-20251017","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jama.2024.2933","article-title":"Individualized treatment effects of oxygen targets in mechanically ventilated critically ill adults.","volume":"331","author":"Buell","year":"2024","journal-title":"JAMA"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:07:47Z","timestamp":1760702867000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001332","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}